Exchange: NASDAQ·Updated 07:50 PM EDT
MRKR logo

MRKR Marker Therapeutics Inc

$0.9601
$0.1099
(10.27%)
Today
Closed $0.9601
$0.0099
(1.03%)
After Hours
Mkt Cap$16.01M
Vol116,806.00

About MRKR

Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company, which engages in the development and commercialization of novel cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company was founded on October 22, 1991 and is headquartered in Houston, TX.
77

Extremely Bullish Sentiment

How do you feel about MRKR?

JeffFaffa
$MRKR 4.2M that they didnt pr in July + 2.6M today is 6.8M cash. With 11.3M as of June 30th - approx 2M burn/qtr places cash currently @ 16M. im expecting 3rd qtr to show approx 14 since this 2M just came in. That means they don't have to dilute until late 2027. That probably explains the little bump here. Ok. Over to you, Vera. it is now yours to fcuk up! And as usual, you do not disappoint in that regard.
1
2
Trak2
$MRKR I think we are better off just holding for a few more months because two major cancer conferences are coming up and companies usually release data around the first week of November. that’s what I feel will happen with MRKR. hopefully it works out for all of us.🙏🏼🙏🏼🙏🏼
4
focafoca99
$MRKR awarded a $2.6 million FDA orphan grant to fund Phase 1 MT-601 pancreatic cancer studies.
3
JeffFaffa
$MRKR they are accepting low asks i tried a few and all went thru. more sellers than buyers at the moment. Retail is fighting it out.
3
GoIrish1776
$MRKR Nevermind, they are likely waiting on FDA feedback on pivotal trial design (extension into 2b) and or data to support that design or path forward. I suspect the two are linked.
3
Trak2
$MRKR this company does know how to get grants. Now, if they could only release some data news
2
zwark1
$MRKR Heard yesterday that there's a big conference happening this weekend at the European Society For Medical Oncology. Lots of companies giving reports and updates on their new cancer treatments. I'm wondering if MRKR will have a presentation there. It would be nice to hear some encouraging updates from them.
1
Trak2
$MRKR the ash cancer conference is in December and companies usually release data in November beforehand, so hopefully this is the case.
2
GoIrish1776
$MRKR Their PR reminds me of the old parent advice, “if you don’t have anything nice [good] to say, don’t say anything at all.”
2
JeffFaffa
$MRKR goes to show the importance of cash in these tadpole companies. it is hovering just above cash value. its like they almost saying to Vera- nothing more until u give us a reason to send it. will he bring something after such long silence? guy is ordinary. i won't hold my breath.
1
GoIrish1776
$MRKR Why did they not give a trial update as they indicated they would? What is going on?
1
itsMeRich
$MRKR this looks like the pump before the dilution….. I’ve seen this too many times before.

Advertisement|Remove ads.